Posts

Doug Drysdale Cybin

Doug Drysdale On How CYB-003 Is Better Than Psilocybin

In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin...

Interview with Sa’ad Shah, Managing Partner at Noetic Fund

In our conversation, Sa’ad gives us an overview of how his interest in philosophy led to his involvement with plant medicine, how the psychedelic industry is currently misunderstood and...
Psychedelic Business Spotlight: June 11, 2021

Psychedelic Business Spotlight: June 11, 2021

,
This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.
Psychedelic Business News Spotlight

Psychedelic Business Spotlight: June 4, 2021

,
This week in psychedelic business: Mindset Pharma's new research, synthetic ibogaine, and the Western Hemisphere gets its first “smart shop.”
Psychedelic Business Spotlight: May 8, 2021

Psychedelic Business Spotlight: May 28, 2021

,
This week in psychedelic business news: NeonMind's Medical Advisory Board, Mynd's public listing, and a new study supports novel use of DMT.
Psychedelic Business Spotlight: May 21, 2021

Psychedelic Business Spotlight: May 21, 2021

This week in psychedelic business news: Therapists cleared to try MDMA, alternative medicine guru promotes psychedelic therapy, and the Swiss green-light new mescaline study. On the heels of the recently...
Business Spotlight

Psychedelic Business News Spotlight: May 14, 2021

This week in psychedelic business news: Therapeutic uses of salvinorin A, a 5-MeO-DMT retreat, and World Boxing Council explores psychedelics.
Psychedelic Business News Spotlight: May 7, 2021

Psychedelic Business News Spotlight: May 7, 2021

This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands is now Braxia Scientific Corp, and more.
Psychedelic Business News Spotlight: April 23, 2021

Psychedelic Business News Spotlight: April 23, 2021

This week in psychedelic business news: Atai to raise $100 million, Silo's psilocybin nasal spray, and more.
Psychedelic Business News Spotlight: April 9, 2021

Psychedelic Business News Spotlight: April 9, 2021

This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a...